Format

Send to

Choose Destination
Cancer Lett. 2006 Nov 28;244(1):86-90. Epub 2006 Jan 19.

COX-2 expression in pseudomyxoma peritonei.

Author information

1
Department of Pathology, Creighton University Medical Center, 601 N 30th Street, Omaha, NE 68131, USA. zgatalica@pathology.creigton.edu

Abstract

COX-2 expression was studied using an immunohistochemical method in 75 patients with pseudomyxoma peritonei (PMP). Twenty-five patients presented with disseminated peritoneal adenomucinosis (DPAM) and 50 with peritoneal mucinous carcinomatosis (PMCA). COX-2 was expressed in neoplastic mucinous epithelium of 30 cases (40%): 20 in PMCA (40%), 10 in DPAM (40%). Weak COX-2 expression was also noted in four of five patients with appendiceal mucinous neoplasms without peritoneal dissemination. In addition, COX-2 was detected in stromal, endothelial, inflammatory cells and reactive mesothelium. This preliminary information indicates a potential for the use of COX-2 inhibitors in patients with PMP.

PMID:
16427185
DOI:
10.1016/j.canlet.2005.12.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center